IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.908
EU - Europa 4.484
AS - Asia 1.925
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 5
AF - Africa 4
OC - Oceania 4
Totale 11.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.887
IE - Irlanda 946
CN - Cina 881
UA - Ucraina 773
SE - Svezia 666
TR - Turchia 660
IT - Italia 640
GB - Regno Unito 439
FR - Francia 354
DE - Germania 261
IN - India 179
SG - Singapore 163
FI - Finlandia 161
RU - Federazione Russa 153
CA - Canada 19
VN - Vietnam 18
CZ - Repubblica Ceca 16
NL - Olanda 15
BE - Belgio 13
PL - Polonia 12
EU - Europa 11
AT - Austria 9
HK - Hong Kong 9
IR - Iran 8
AL - Albania 6
JP - Giappone 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
AU - Australia 3
CH - Svizzera 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
CL - Cile 2
DK - Danimarca 2
ES - Italia 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
EG - Egitto 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 11.344
Salva come PNG Salva come JPEG
Città #
Chandler 1.086
Jacksonville 958
Dublin 932
Princeton 383
Ashburn 375
Southend 370
Izmir 335
Nanjing 234
Dearborn 205
Wilmington 185
Beijing 181
Cambridge 159
Ann Arbor 144
Altamura 134
Chieti 104
Nanchang 99
Singapore 96
Boardman 88
New York 69
Washington 63
Hebei 48
Shenyang 48
Kunming 44
Woodbridge 44
Tianjin 40
Jiaxing 31
Grevenbroich 30
Norwalk 29
Changsha 28
Los Angeles 27
Rome 26
Augusta 25
Moscow 25
Seattle 20
Pescara 19
Dong Ket 18
Jinan 18
Changchun 17
Lanzhou 17
San Mateo 17
Toronto 17
Hangzhou 16
Falls Church 15
Helsinki 15
Brno 14
Brussels 13
Milan 12
Amsterdam 10
Leawood 10
Pune 10
Caserta 8
Munich 8
Ningbo 8
Tappahannock 7
Bologna 6
Hong Kong 6
Kocaeli 6
Shanghai 6
Tirana 6
Fairfield 5
Grugliasco 5
Orange 5
Paris 5
Zhengzhou 5
Ancona 4
Cagliari 4
Campobasso 4
Chicago 4
Delhi 4
Florence 4
Fuzhou 4
Hefei 4
Houston 4
Monmouth Junction 4
Mountain View 4
Palermo 4
Radomsko 4
Reggio Calabria 4
Teramo 4
Anzola Dell'emilia 3
Ardabil 3
Catania 3
Clifton 3
Denver 3
Edinburgh 3
Frankfurt am Main 3
Guangzhou 3
Kraków 3
Legnano 3
London 3
Naples 3
Rio Saliceto 3
San Vito Chietino 3
Taiyuan 3
Tokyo 3
Wuhan 3
Altino 2
Ascoli Piceno 2
Athens 2
Bari 2
Totale 7.108
Salva come PNG Salva come JPEG
Nome #
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 114
Role of growth factors in the development of diabetic complications 110
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 108
Pentraxin 3 and platelet activation in obese patients after gastric banding 107
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 106
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 102
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 100
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 100
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 98
Neurocognitive impairment and suicide risk among prison inmates 96
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 96
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 95
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 91
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 89
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 89
Platelets and Diabetes 88
Platelet activation in obesity and metabolic syndrome. 87
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 87
The role of nitric oxide in the development of diabetic angiopathy. 86
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 86
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 86
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 85
Determinants of platelet activation in hypertensives with microalbuminuria. 84
The role of antileukotrienes in the treatment of asthma. 84
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 83
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 83
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 83
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 82
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 82
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 81
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 80
Platelets and diabetes mellitus 80
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 79
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 79
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 79
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 78
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 78
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 78
Soluble forms of RAGE in internal medicine. 78
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 78
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 77
Coagulation and infective endocarditis: sooner or later 77
Atherothrombotic disease and the metabolic syndrome. 76
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 76
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 76
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 75
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 75
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 75
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 75
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 75
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 74
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 73
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 72
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 72
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 72
Soluble RAGE in type 2 diabetes: association with oxidative stress. 71
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 71
The left atrial appendage: from embryology to prevention of thromboembolism 71
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 71
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 70
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 70
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 69
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 69
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 69
Effectiveness of Montelukast versus Budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma 69
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 68
Nutraceuticals in diabetes and metabolic syndrome. 68
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 68
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 68
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 68
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 68
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 68
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 67
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 67
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 66
Association between PAI-1 and Oxidative Stress in Android Obesity 66
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 66
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 66
Oxidative stress in chronic vascular disease: From prediction to prevention 66
Thrombin as a common downstream target blocking both platelet and monocyte activation 65
Unveiling the inflammatory face of antiplatelet drugs. 65
Enhanced soluble CD40 ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control 65
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 65
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 65
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever 65
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 65
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 65
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. 64
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 64
Insulin resistance as a determinant of platelet activation in obese women 64
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 64
Aspirin as antiplatelet agent in diabetes. PROS-. 64
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 63
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 63
Determinants of platelet activation in hypertensives with microalbuminuria. 63
Association between enhanced soluble CD40 ligand and platelet activation in hypertensives with microalbuminuria. 63
Diabetes mellitus 62
Totale 7.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.723 0 149 32 37 207 141 290 227 89 294 235 22
2020/20211.105 191 17 202 20 58 242 31 28 102 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/2025250 242 8 0 0 0 0 0 0 0 0 0 0
Totale 12.411